[128] By contrast, other DAT inhibitors including bupropion haven't been noticed to exhibit this result.[129] These observations have prompted the hypothesis that methylphenidate may work as a "DAT inverse agonist" or "detrimental allosteric modifier on the DAT" by reversing the path of the dopamine efflux because of the DAT at better dosages.[one